vs
BALCHEM CORP（BCPC）与CI&T Inc（CINT）财务数据对比。点击上方公司名可切换其他公司
CI&T Inc的季度营收约是BALCHEM CORP的1.9倍（$489.6M vs $263.6M），BALCHEM CORP净利率更高（14.9% vs 8.3%，领先6.6%），CI&T Inc同比增速更快（11.5% vs 9.8%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
CI&T Inc是全球数字化转型服务提供商，提供定制软件开发、云迁移、数据分析、用户体验设计、人工智能落地等端到端解决方案，服务零售、金融、医疗、制造等多个行业客户，业务覆盖美洲、欧洲及亚太地区。
BCPC vs CINT — 直观对比
营收规模更大
CINT
是对方的1.9倍
$263.6M
营收增速更快
CINT
高出1.7%
9.8%
净利率更高
BCPC
高出6.6%
8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $489.6M |
| 净利润 | $39.2M | $40.6M |
| 毛利率 | 35.6% | 32.0% |
| 营业利润率 | 19.8% | 13.4% |
| 净利率 | 14.9% | 8.3% |
| 营收同比 | 9.8% | 11.5% |
| 净利润同比 | 16.8% | 37.7% |
| 每股收益（稀释后） | $1.21 | $0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCCINT
| Q4 25 | $263.6M | $489.6M | ||
| Q3 25 | $267.6M | — | ||
| Q2 25 | $255.5M | — | ||
| Q1 25 | $250.5M | — | ||
| Q4 24 | $240.0M | $439.0M | ||
| Q3 24 | $239.9M | — | ||
| Q2 24 | $234.1M | — | ||
| Q1 24 | $239.7M | — |
净利润BCPCCINT
| Q4 25 | $39.2M | $40.6M | ||
| Q3 25 | $40.3M | — | ||
| Q2 25 | $38.3M | — | ||
| Q1 25 | $37.1M | — | ||
| Q4 24 | $33.6M | $29.5M | ||
| Q3 24 | $33.8M | — | ||
| Q2 24 | $32.1M | — | ||
| Q1 24 | $29.0M | — |
毛利率BCPCCINT
| Q4 25 | 35.6% | 32.0% | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | 34.2% | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 34.0% | — |
营业利润率BCPCCINT
| Q4 25 | 19.8% | 13.4% | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.1% | — | ||
| Q1 25 | 20.4% | — | ||
| Q4 24 | 19.8% | 12.7% | ||
| Q3 24 | 20.0% | — | ||
| Q2 24 | 19.6% | — | ||
| Q1 24 | 17.4% | — |
净利率BCPCCINT
| Q4 25 | 14.9% | 8.3% | ||
| Q3 25 | 15.1% | — | ||
| Q2 25 | 15.0% | — | ||
| Q1 25 | 14.8% | — | ||
| Q4 24 | 14.0% | 6.7% | ||
| Q3 24 | 14.1% | — | ||
| Q2 24 | 13.7% | — | ||
| Q1 24 | 12.1% | — |
每股收益（稀释后）BCPCCINT
| Q4 25 | $1.21 | $0.30 | ||
| Q3 25 | $1.24 | — | ||
| Q2 25 | $1.17 | — | ||
| Q1 25 | $1.13 | — | ||
| Q4 24 | $1.03 | $0.22 | ||
| Q3 24 | $1.03 | — | ||
| Q2 24 | $0.98 | — | ||
| Q1 24 | $0.89 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $47.9M |
| 总债务越低越好 | — | $122.6M |
| 股东权益账面价值 | $1.3B | $308.9M |
| 总资产 | $1.7B | $550.5M |
| 负债/权益比越低杠杆越低 | — | 0.40× |
8季度趋势，按日历期对齐
现金及短期投资BCPCCINT
| Q4 25 | $74.6M | $47.9M | ||
| Q3 25 | $65.1M | — | ||
| Q2 25 | $65.4M | — | ||
| Q1 25 | $49.9M | — | ||
| Q4 24 | $49.5M | $56.6M | ||
| Q3 24 | $73.7M | — | ||
| Q2 24 | $63.7M | — | ||
| Q1 24 | $60.3M | — |
总债务BCPCCINT
| Q4 25 | — | $122.6M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $138.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BCPCCINT
| Q4 25 | $1.3B | $308.9M | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.1B | $280.1M | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
总资产BCPCCINT
| Q4 25 | $1.7B | $550.5M | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.6B | $526.4M | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.6B | — |
负债/权益比BCPCCINT
| Q4 25 | — | 0.40× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | — | $45.8M |
| 自由现金流率自由现金流/营收 | — | 9.4% |
| 资本支出强度资本支出/营收 | — | 3.0% |
| 现金转化率经营现金流/净利润 | 1.72× | 1.49× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BCPCCINT
| Q4 25 | $67.3M | $60.6M | ||
| Q3 25 | $65.6M | — | ||
| Q2 25 | $47.3M | — | ||
| Q1 25 | $36.5M | — | ||
| Q4 24 | $52.3M | $69.0M | ||
| Q3 24 | $51.3M | — | ||
| Q2 24 | $45.0M | — | ||
| Q1 24 | $33.4M | — |
自由现金流BCPCCINT
| Q4 25 | — | $45.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $58.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率BCPCCINT
| Q4 25 | — | 9.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度BCPCCINT
| Q4 25 | — | 3.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率BCPCCINT
| Q4 25 | 1.72× | 1.49× | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | 2.34× | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
CINT
暂无分部数据
